CoChat
Sign Up
Cited by 2Historical Psychiatry and Medical PracticesMental Health Treatment and AccessPharmaceutical Economics and Policy

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Psychopharmaceuticals as ‘Essential Medicines’: Local Negotiations of Global Access to Psychotherapeutic Medicines in India

Mills, China·2017·The Sedated Society
DOI 10.1007/978-3-319-44911-1_9
Open this paper in CoChat — free account

Overview

Integrity signals

Registry

Crossref · 10.1007/978-3-319-44911-1_9

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Mills points out that the rationale for including psychopharmaceuticals in the Essential Medicine List has roots in the same discursive justification that supported colonial-era psychiatric institutions: a narrative of universal mental disorders and a moral obligation to provide care in the name of shared humanity.

    “Mills (2017) has pointed out that the rationale behind the inclusion of psychopharmaceuticals in the Essential Medicine List has its roots in the same discursive justification which supported the establishment of psychiatric institutions under colonial rule -that is, a narrative centred around a fundamental universality of mental disorders, and evoking a moral and ethical obligation to provide”

    From Throwing therapy at the problem mental health and humanitarian intervention in Palabek refugee settlement, northern Uganda (2023) · cites this paper as Mills 2017

  • EML inclusion was a turning point in psychopharmaceutical expansion in low- and middle-income countries, constructing psychotropic treatment as essential and beneficial.

    “The inclusion of psychopharmaceuticals in the EML constituted a significant turning point in their expansion in low-and middle-income countries, constructing psychotropic treatment as 'essential' and 'beneficial' (Mills 2017).”

    From Throwing therapy at the problem mental health and humanitarian intervention in Palabek refugee settlement, northern Uganda (2023) · cites this paper as Mills 2017

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 43

  1. All Party Parliamentary Groups (APPG). (2014). Mental health and sustainable development. London: Mental Health Innovation Network and APPG.
  2. Appadurai, A. (1986). The social life of things: Commodities in cultural perspective. Cambridge: Cambridge University Press. · DOI · Paper page
  3. Barbui, C., & Purgato, M. (2014). Decisions on WHO’s essential medicines need more scrutiny. British Medical Journal, 349, g4798. · DOI
  4. Breggin, P. R. (2008). Brain-disabling treatments: Drugs, electroshock, and the psychopharmaceutical complex. New York: Springer.
  5. Cohen, A. (2014). Crazy for Ya Ba: Metamphetamine use among Northern Thai youth. International Journal of Drug Policy, 25, 776–782. · DOI
  6. Davar, B. (2014). Globalizing psychiatry and the case of ‘vanishing’ alternatives in a neo-colonial state. Disability and the Global South: An International Journal, 1(2), 266–284.
  7. Ecks, S., & Basu, S. (2009). How wide is the “treatment gap” for antidepressants in India? Ethnographic insights in private industry marketing strategies. Journal of Health Studies, II, 68–80.
  8. Fernando, S. (2014). Mental health worldwide: Culture, globalization and development. New York: Palgrave Macmillan. · DOI
  9. Fernando, S., & Weerackody, C. (2009). Challenges in developing community mental health services in Sri Lanka. Journal of Health Management, 11(1), 195–208. · DOI
  10. Goldacre, B. (2012). Bad pharma: How drug companies mislead doctors and harm patients. London: Fourth Estate.
  11. Greene, J. A. (2010). When did medicines become essential? Bulletin of the World Health Organization, 88, 483–483. · DOI
  12. Hardon, A., & Ihsan, A. (2014). Somadril and edgework in South Sulawesi. International Journal of Drug Policy, 25, 755–761. · DOI
  13. Healy, D. (2012). Pharmageddon. Berkeley, LA: University of California Press. · DOI
  14. Horwitz, A. V., & Wakefield, J. C. (2006). The epidemic in mental illness: Clinical fact or survey artifact? Contexts, 5(1), 19–23. · DOI
  15. Horwitz, A. V., & Wakefield, J. C. (2007). Loss of sadness: How psychiatry transformed normal sorrow into depressive disorder. Oxford: Oxford University Press. · DOI
  16. Ingleby, D. (2014). How ‘evidence-based’ is the movement for global mental health? Disability and the Global South: An International Journal, 1(2), 203–226.
  17. Jain, S., & Jadhav, S. (2009). Pills that swallow policy: Clinical ethnography of a community mental health program in Northern India. Transcultural Psychiatry, 46(1), 60–85. · DOI
  18. Lancet Global Mental Health Group. (2007). Scale up services for mental disorders: A call for action. The Lancet, 370(9594), 1241–1252. · DOI · Paper page
  19. Larner, W., & Craig, D. (2005). After Neoliberalism? Community activism and local partnerships in Aotearoa New Zealand. In N. Laurie & L. Bondi (Eds.), Working the spaces of neoliberalism. Malden, Oxford, and Victoria: Blackwell Publishing.
  20. LeFrançois, B. A., Menzies, R., & Reaume, G. (Eds.). (2013). Mad matters: A critical reader in Canadian mad studies. Toronto: Canadian Scholars Press.
  21. Mathers, C. D., & Loncar, D. (2006). Projections of global mortality and burden of disease from 2002 to 2030. Public Library of Science Medicine, 3, e442.
  22. Mathers, C. D., & Loncar, D. (2005). Updated projections of global mortality and burden of disease, 2002–2030: Data sources, methods and results. Geneva: World Health Organization.
  23. Melrose, D. (1982). Bitter pills: Medicines and the third world poor. Oxford: Oxfam.
  24. Mills, C. (2014). Decolonizing global mental health: The psychiatrization of the majority world. London and New York: Routledge. · DOI · Paper page
  25. Mills, C. (2016). Mental health and the global mindset of development. In J. Grugel & D. Hammett (Eds.), The Palgrave handbook of international development. London: Palgrave.
  26. Moncrieff, J. (2009). The myth of the chemical cure. A critique of psychiatric drug treatment. Basingstoke: Palgrave Macmillan.
  27. Pan-African Network of People with Psychosocial Disabilities. (2012). Press Package. Online. Retrieved July 12, 2012, from http://www.panusp.org/wp-content/uploads/2011/10/Press-Release-WHO-Launch-Toolkit-28-June-2012.pdf
  28. Patel, V. (2006). Beyond evidence: The moral case for international mental health. American Journal of Psychiatry, 163(9), 1312–1315. · DOI
  29. Patel, V. (2007). Mental health in low- and middle-income countries. British Medical Bulletin, 1–16. · DOI
  30. Patel, V. (2014). Why mental health matters to global health. Transcultural Psychiatry, 51, 777–789. · DOI
  31. Patel, V., & Andrade, C. (2003). Pharmacological treatment of severe psychiatric disorders in the developing world: Lessons from India. CNS Drugs, 17(15), 1071–1080. · DOI
  32. Patel, V., Collins, P. Y., Copeland, J., Kakuma, R., Katontoka, S., Lamichhane, J., et al. (2011b). The movement for global mental health. British Journal of Psychiatry, 198, 88–90. · DOI
  33. Prince, M., Patel, V., Saxena, S., Maj, M., Maselko, J., Phillips, M. R., et al. (2007). No health without mental health. The Lancet, 370(9590), 1–19. · DOI
  34. Shah, S. (2006). The body hunters; Testing new drugs on the world’s poorest patients. New York and London: The New Press.
  35. Summerfield, D. (2008). How scientifically valid is the knowledge base of global mental health? British Medical Journal, 336, 992–994. · DOI · Paper page
  36. Timimi, S., & Radcliffe, N. (2005). The rise and rise of ADHD. In C. Newnes & N. Radcliffe (Eds.), Making and breaking children’s lives (pp. 63–70). Ross-on Wye: PCCS Books.
  37. Van der Geest, S., Whyte, S. R., & Hardon, A. (1996). The anthropology of pharmaceuticals: A biographical approach. Annual Review of Anthropology, 25, 153–178. · DOI
  38. Watters, E. (2010). Crazy like us: The globalization of the American psyche. New York and London: Free Press.
  39. WHO. (2001a). World health report 2001: Mental health: New understanding, new hope. Geneva: World Health Organisation.
  40. WHO. (2001b). Mental health: A call for action by world health ministers. Ministerial round tables, 54th world health assembly. Geneva: World Health Organization.
  41. World Health Organization. (2010a). Mental health and development: Targeting people with mental health conditions as a vulnerable group. Geneva: WHO.
  42. World Health Organization. (2010b). mhGAP intervention guide for mental, neurological and substance use disorders in non-specialized health settings: Mental health Gap Action Programme (mhGAP). Geneva: WHO.
  43. World Health Organization. (2013). Comprehensive mental health action plan 2013–2020. Geneva: WHO.

Cited by

Sorted by citations

Metadata

Authors
Mills, C.
Affiliations
University of Sheffield (GB)
Corresponding author
Mills, China
ORCID
Mills, China
Venue
The Sedated Society
Publisher
Springer International Publishing
Published
2017
Pages
227-248
DOI
10.1007/978-3-319-44911-1_9
OpenAlex
W2585214288
Cited by
2
References
2
Citations by year
2021: 1 · 2017: 1
FWCI
1.75
Type
book chapter
Language
en
Open access
closed
Licence
www.springer.com/tdm (unspecified)
Locations
Springer eBooks (publishedVersion)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Historical Psychiatry and Medical Practices
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
Keywords
psychotropic drugs, essential medicines, global mental health, drug distribution, global health advocacy, India

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review